K223042

Substantially Equivalent

Viz LVO ContaCT

Applicant: Viz. Ai, Inc.
Product code: QAS
Advisory panel: Radiology
Date received: 2022-09-29
Decision date: 2022-10-21
Decision: Substantially Equivalent
Clearance type: Special
Location: San Francisco, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.